Transport
ST. Francis Medical Center
ST. Francis Medical Center was paid $1.66M by Medicaid between Jan 2018 and Oct 2024, across 34 billing codes. Its largest line is 99283, emergency room visit (moderate) — 38% of everything it billed.
33Billing provider infoST. FRANCIS MEDICAL CENTER
BRECKENRIDGE, MN 56520
BRECKENRIDGE, MN 56520
33aNPI1639162381assigned 08/29/2005
33bProvider typeAmbulance
28Total paid$1.66M
24GClaims19,303
24DCodes billed34
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ambulance providers in Minnesota
Rank by total paid#7 of 34
Median peer was paid$123K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,117 | $236K | |
| 2019 | 2,712 | $224K | |
| 2020 | 1,679 | $125K | |
| 2021 | 2,620 | $221K | |
| 2022 | 3,355 | $254K | |
| 2023 | 3,882 | $400K | |
| 2024incomplete | 1,938 | $199K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 38% | 2,773 | 2,164 | $623K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 1,395 | 995 | $558K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 470 | 286 | $209K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 2,558 | 1,834 | $45K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 241 | 173 | $40K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 2,209 | 1,412 | $36K |
| 80053 | Comprehensive metabolic panel | 1.7% | 1,457 | 1,060 | $28K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 2,891 | 2,020 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 289 | 200 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 173 | 121 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 127 | 92 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 147 | 96 | $8K |
22 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 123 | $7K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 43 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 343 | $6K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 96 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 275 | $5K |
| 81001 | <1% | 657 | $4K | |
| 0240U | <1% | 36 | $3K | |
| 84484 | <1% | 128 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 125 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 45 | $2K |
| 83735 | <1% | 143 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $1K |
| 86140 | <1% | 86 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 91 | $917.13 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 73 | $470.63 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 18 | $437.25 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 37 | $379.78 |
| 85610 | <1% | 54 | $355.29 | |
| A9270 | Non-covered item or service | <1% | 2,067 | $230.59 |
| 87430 | <1% | 20 | $191.07 | |
| J3490 | Unclassified drugs | <1% | 78 | $96.44 |
| 99443 | <1% | 20 | $66.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSS, JAY (VP OF FINANCE OPERATION)